Phase 3 Multicenter Randomized Trial of PSMA PET/CT Prior to Definitive Radiation Therapy for Unfavorable Intermediate-Risk or High-Risk Prostate Cancer [PSMA dRT]: Study Protocol – Beyond the Abstract

PSMA PET/CT molecular imaging can improve outcomes in patients with prostate cancer, current standard-of-care imaging techniques for prostate cancer, PSMA PET imaging, radiation therapy after the PSMA PET imaging.

Read the full article here

Related Articles